FDA Approves Esketamine Nasal Spray for Resistant Depression FDA Approves Esketamine Nasal Spray for Resistant Depression

The US Food and Drug Administration has approved esketamine nasal spray (Spravato, Janssen Pharmaceuticals) for treatment-resistant depression.FDA Approvals
Source: Medscape Internal Medicine Headlines - Category: Internal Medicine Tags: Psychiatry News Alert Source Type: news